Physician

Abdul Aziz, M.D.

According to 2025 Medicare claims, Abdul Aziz, M.D. (NPI: 1811973696) practices rheumatology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Osceola, FL. This provider's primary affiliated billing organization is FLORIDA ARTHRITIS & RHEUMATISM, INC. (NPI: 1497731491; TIN: 550881208) and primary practice location at 34741-4443.

Aziz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 241 traditional Medicare patients, billed 37,189 HCPCS/CPT codes, and received $350,679 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,588 prescription claims across 1,193 beneficiaries totaling $3,833,496 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 202 records totaling $3,519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $96,237 to $350,679. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$238K$477K2015 Medicare payment: $96,237 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $143,646 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $270,370 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $330,607 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $419,492 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $476,529 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $474,515 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $387,865 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $365,361 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $350,679 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154081,339$96,237
20164062,449$143,646
201738418,073$270,370
201834922,474$330,607
201931332,491$419,492
202027534,657$476,529
202125728,135$474,515
202222638,052$387,865
202323640,380$365,361
202424137,189$350,679

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.8M2015 Drug cost: $2,247,062 (USD; Tot_Drug_Cst)2016 Drug cost: $1,916,762 (USD; Tot_Drug_Cst)2017 Drug cost: $1,907,101 (USD; Tot_Drug_Cst)2018 Drug cost: $2,662,120 (USD; Tot_Drug_Cst)2019 Drug cost: $2,725,854 (USD; Tot_Drug_Cst)2020 Drug cost: $2,303,323 (USD; Tot_Drug_Cst)2021 Drug cost: $2,141,705 (USD; Tot_Drug_Cst)2022 Drug cost: $2,027,477 (USD; Tot_Drug_Cst)2023 Drug cost: $2,194,916 (USD; Tot_Drug_Cst)2024 Drug cost: $3,833,496 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,0859,275$2,247,062
20169857,669$1,916,762
20179326,818$1,907,101
20189316,237$2,662,120
20199415,670$2,725,854
20209455,584$2,303,323
20219895,751$2,141,705
20229755,476$2,027,477
20231,0586,065$2,194,916
20241,1936,588$3,833,496

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7979$121
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more218564$90
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle34170$53
J0897Injection, denosumab, 1 mg262,400$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept1123,332$896,616
Humira(Cf) PenAdalimumab792,492$607,062
RinvoqUpadacitinib572,070$425,482
Orencia ClickjectAbatacept411,260$254,402
OrenciaAbatacept/Maltose561,568$253,971

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.202$3,519Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdul Aziz, M.D.?

Tedicare shows public-source Medicare data for Abdul Aziz, M.D. (NPI 1811973696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Aziz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul Aziz, M.D.?

Abdul Aziz, M.D. is linked to FLORIDA ARTHRITIS & RHEUMATISM, INC. (billing NPI 1497731491) in the available physician profile data.

Does Abdul Aziz, M.D. have Open Payments data?

Abdul Aziz, M.D. has 202 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.